Otsuka Holdings Co Ltd
TSE:4578

Watchlist Manager
Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd
TSE:4578
Watchlist
Price: 8 910 JPY -0.47% Market Closed
Market Cap: 4.8T JPY
Have any thoughts about
Otsuka Holdings Co Ltd?
Write Note
Otsuka Holdings Co Ltd
/
Balance Sheet
/
Accounts Receivables

Otsuka Holdings Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Otsuka Holdings Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Otsuka Holdings Co Ltd
TSE:4578
Accounts Receivables
¥470.4B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
4%
Takeda Pharmaceutical Co Ltd
TSE:4502
Accounts Receivables
¥700.5B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
4%
Daiichi Sankyo Co Ltd
TSE:4568
Accounts Receivables
¥531.8B
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
7%
S
Shionogi & Co Ltd
TSE:4507
Accounts Receivables
¥131.1B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
7%
Chugai Pharmaceutical Co Ltd
TSE:4519
Accounts Receivables
¥239.7B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
6%
Astellas Pharma Inc
TSE:4503
Accounts Receivables
¥587.7B
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
6%
No Stocks Found

Otsuka Holdings Co Ltd
Glance View

Market Cap
4.8T JPY
Industry
Pharmaceuticals

Otsuka Holdings Co., Ltd. is a Japanese pharmaceutical and nutraceutical powerhouse, woven into the fabric of global health and wellness. Founded in 1964, the company has consistently focused on the discovery, development, and commercialization of innovative products aimed at tackling unaddressed medical needs. Otsuka's broad portfolio includes prescription drugs, particularly in the areas of psychiatry, neurology, and oncology, complemented by a robust range of consumer healthcare products such as drinks and nutritional supplements. With a commitment to research and development, the company invests significantly in innovative drug solutions, resulting in a legacy marked by breakthroughs such as Abilify, a treatment for schizophrenia and bipolar disorder, and an array of lifestyle products that support overall well-being. For investors, Otsuka Holdings presents an intriguing blend of stability and growth potential. Its diversified business model mitigates dependence on any single market segment. The company’s strong financial foundation, supported by solid revenue from both its pharmaceutical and consumer health divisions, highlights its resilience even in challenging economic conditions. As Otsuka continues to expand its global footprint, particularly in emerging markets and through strategic partnerships, it positions itself to capitalize on the growing demand for innovative therapies and nutritional products. The company’s robust commitment to sustainability and social responsibility further enhances its attractiveness to investors looking for long-term value. With a vision centered on health, innovation, and quality of life, Otsuka stands as a formidable player in the healthcare landscape, poised for growth while delivering on its mission to create new products for a healthier world.

Intrinsic Value
9 473.82 JPY
Undervaluation 6%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Otsuka Holdings Co Ltd's Accounts Receivables?
Accounts Receivables
470.4B JPY

Based on the financial report for Sep 30, 2024, Otsuka Holdings Co Ltd's Accounts Receivables amounts to 470.4B JPY.

What is Otsuka Holdings Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
4%

Over the last year, the Accounts Receivables growth was -6%. The average annual Accounts Receivables growth rates for Otsuka Holdings Co Ltd have been 9% over the past three years , 6% over the past five years , and 4% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.